title: Control_brain_CB_rep8

value: female

value: Control 15


title: Control_brain_CB_rep11

status: Public on Jul 22 2011

type: RNA

city: Bethesda

first: Mark

last: Cookson

state: MD

address: 35 CONVENT DR RM 1A116

department: Lab of Neuorgenetics

country: USA

institute: NIA, NIH

hyb_protocol: Standard Illumina hybridization protocol.

scan_protocol: Standard Illumina scanning protocol.

data_processing: Illumina BeadStudio software suite: quantile normalization with background subtraction on a per brain region basis to generate expression values for each probe.

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: Brain tissue (cerebellum), control

label_protocol: RNA was amplified using the Illumina TotalPrep RNA amplification kit, resulting in biotin-labeled cRNA.

extract_protocol: RNA from different brain regions was extracted from flash-frozen tissue using Trizol (Invitrogen) and stored at -80°C until use.

tag: tissue

value: brain

tag: brain region

value: cerebellum

tag: disease state

value: control

tag: gender

tag: age

tag: individual identifier

value: Control 18


title: NZB Backcross animal 3290

city: Rockville

first: Ying

last: Hu

email: yhu@mail.nih.gov, hunterk@mail.nih.gov

address: 9609 Medical Center Dr.

department: NCI/CCR

institute: NIH

description: Spontaneous mammary tumors induced by MMTV-PyMT transgene

hyb_protocol: GeneChip® Hybridization, Wash and Stain Kit: (Affymetrix, P/N 900720) following manufacture’s protocol for One-Cycle cDNA Synthesis Kit Protocol for Eukaryotic Target Prepartion, Affymetrix)

scan_protocol: GCOSv1.4, Affymetrix Fluidics Station 450 (FS450_0001), Gene ChIP Scanner 3000 7G

data_processing: GCOSv1.4, Scaling: default (500), Normalization: User defined=1, RMA normalization using BioConductor

organism: Mus musculus

source_name: PyMT-induced mammary tumor

label_protocol: GeneChip® One-Cycle Target Labeling and Control Reagents (Affymetrix, P/N 900493) following manufacture’s protocol.

extract_protocol: Trizol (Invitrogen), following manufacturers protocol, RNeasy Mini Kit (Qiagen)

tag: strain background

value: ((NZB x PyMT) x FVB) backcross

value: NZB x PyMT backcross mammary tumor


title: Control_brain_CB_rep10

value: Control 17


title: NZB Backcross animal 3289


title: NZB Backcross animal 3296R


title: NZB Backcross animal 3199


title: Control_brain_CB_rep5

value: male

value: Control 9


title: Control_brain_CB_rep6

value: Control 10


title: NZB Backcross animal 3197


title: trans gene B(FoB) Rep1

city: La Jolla

first: Steven

last: Head

state: CA

address: 10550 N Torrey Pines Rd

institute: The Scripps Research Institute

description: miR-17-92 transgenic allele (termed miR-17-92 Tg) whose expression can be turned on conditionally by Cre recombinase (Xiao et al, Nature Immunology, 9:405-14, 2008)

hyb_protocol: Following fragmentation and end labeling, 5.0 ug of cDNA was hybridized for 16 hr at 45C on the Mouse Gene 1.0 ST Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.

scan_protocol: GeneChips were scanned using the Affymetrix 3000 7G scanner.

data_processing: The data were analyzed with RMA Express using the default settings (Background Adjust - Yes, Normalization - Quantile, Summarization Method - Median Polish, Store Residuals - unchecked). CDFRME file used for analysis: MoGene_CDFRME.zip.

source_name: Follicular B(FoB) cells were purified from CD19-Cre;miR-17~92 Tg/Tg mice

label_protocol: Biotinylated cDNA was generated using the NuGEN Applause WT Amp ST System. cDNA was fragmented and labeled using the NuGEN Encore Biotin Module.

extract_protocol: Total RNA was extracted using Qiagen Rneasy kits according to the manufacturer's instructions.

tag: cell type

value: Follicular B (FoB)

tag: genotype/variation

value: CD19-Cre;miR-17~92 Tg/Tg mice


title: NZB Backcross animal 3053


title: Control_Oscillatory_rep4

city: Durham

first: Charles

middle: S

last: Wallace

state: North Carolina

address: 100 Science Drive

department: Biomedical Engineering

institute: Duke University

hyb_protocol: Performed by the Duke University Microarray Facility. See following website for detailed protocols: http://www.genome.duke.edu/cores/microarray/services/spotted-arrays/protocols/

data_processing: GeneSpring GX 11.0 was used for lowess normalization and log2 transformation.  The baseline transformation was completed to the median of all samples. Intensity was filtered for 12 of 24 samples between 50-65486

organism: Sus scrofa

source_name: Endothelial cell, Control, Oscillatory Shear

growth_protocol: The aorta was removed from female juvenile farm swine and the primary cells were isolated by scraping at Duke University. Porcine Aortic Endothelial Cells were used between passage 3-6. Cells were seeded on fibronectin coated glass slides so that cells were confluent in 2-3 days.

extract_protocol: Total RNA was isolated using Qiagen's Rneasy Micro Kit and one round of amplification was preformed using Applied Biosystems/Ambion's MessageAmpTM II aRNA Amplification Kit

treatment_protocol: Cells were exposed to either Non-reversing (15 ± 15 dyne/cm2, 1 Hz), Steady (15 dyne/cm2), or Oscillatory (0 ± 15 dyne/cm2, 1 Hz) shear for 24 hours with or without the addition of 300 mU/ml heparinase III to the flow media.

value: Porcine Aortic Endothelial Cells

source_name: Reference, Endothelial Cells, Static


title: Control_brain_CB_rep3

value: Control 7


title: Heparinase_Oscillatory_rep4

scan_protocol: Performed by the Duke University Microarray Facility. See following website for detailed protocols: http://www.genome.duke.edu/cores/microarray/services/spotted-arrays/protocols/

source_name: Endothelial cell, Heparinase Treated, Oscillatory Shear


title: Control_Steady_rep4

source_name: Endothelial cell, Control, Steady Shear

label_protocol: Performed by the Duke University Microarray Facility. See following website for detailed protocols: http://www.genome.duke.edu/cores/microarray/services/spotted-arrays/protocols/


title: Control_brain_CB_rep4

value: Control 8


title: trans gene B(FoB) Rep2


title: trans gene B(FoB) Rep3


title: Heparinase_Steady_rep4

source_name: Endothelial cell, Heparinase Treated, Steady Shear


title: NZB Backcross animal 3042


title: wild type B(FoB) Rep1

source_name: Follicular B(FoB) cells were purified from miR-17~92 Tg/Tg mice

value: miR-17~92 Tg/Tg mice


title: Control_Non-reversing_rep4

source_name: Endothelial cell, Control, Non-reversing Shear


title: Control_brain_CB_rep1

value: Control 2


title: NZB Backcross animal 3039R


title: wild type B(FoB) Rep2


title: Control_brain_CB_rep2

value: brain

value: Control 3


title: PD_brain_FCX_rep11

source_name: Brain tissue (frontal cortex), PD

value: frontal cortex

value: Parkinson's disease

value: female

value: IPD 15


title: NZB Backcross animal 3046

value: ((NZB x PyMT) x FVB) backcross

value: NZB x PyMT backcross mammary tumor


title: PD_brain_FCX_rep10

value: male

value: IPD 13


title: Control_Oscillatory_rep3


title: NZB Backcross animal 3001


title: Heparinase_Non-reversing_rep4

source_name: Endothelial cell, Heparinase Treated, Non-reversing Shear


title: Heparinase_Oscillatory_rep3


title: Control_Non-reversing_rep3


title: Heparinase_Steady_rep3


title: PD_brain_FCX_rep9

value: IPD 12


title: PD_brain_FCX_rep8

value: IPD 10


title: Control_Oscillatory_rep2

value: Porcine Aortic Endothelial Cells


title: Control_Steady_rep3


title: Heparinase_Oscillatory_rep2


title: Heparinase_Non-reversing_rep3


title: NZB Backcross animal 2703


title: Control_Steady_rep2


title: Heparinase_Non-reversing_rep2


title: Heparinase_Steady_rep2


title: Control_Non-reversing_rep2


title: NZB Backcross animal 2426


title: NZB Backcross animal 2421


title: PD_brain_FCX_rep7

value: IPD 9


title: NZB Backcross animal 2424


title: PD_brain_FCX_rep5

value: IPD 5


title: NZB Backcross animal 3004


title: wild type B(FoB) Rep3

value: Follicular B (FoB)

value: miR-17~92 Tg/Tg mice


title: PD_brain_FCX_rep6

value: brain

value: IPD 6


title: Control_Oscillatory_rep1


title: Heparinase_Oscillatory_rep1


title: Heparinase_Steady_rep1


title: Heparinase_Non-reversing_rep1

growth_protocol: The aorta was removed from female juvenile farm swine and the primary cells were isolated by scraping at Duke University. The aorta was removed from female juvenile farm swine and the primary cells were isolated by scraping at Duke University. Porcine Aortic Endothelial Cells were used between passage 3-6. Cells were seeded on fibronectin coated glass slides so that cells were confluent in 2-3 days.


title: Control_Non-reversing_rep1


title: Liver_KrillOil_rep7

city: Madison

first: Jamie

last: Barger

state: WI

address: 510 Charmany Drive, Suite 263

institute: LifeGen Technologies, LLC

description: Mouse fed diet containing krill oil

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on the Affymetrix Mouse Genome 430 2.0 array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.

scan_protocol: GeneChips were scanned using the Affymetrix GeneArray Scanner 3000.

data_processing: The data were analyzed with GeneChip Operating System 1.2 (GCOS 1.2) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 500.

source_name: Liver, KrillOil, rep7

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

treatment_protocol: Male CBA/J mice were purchased from Jackson Laboratory at six weeks of age and were individually housed and fed 84 kcal/week of a diet based on the AIN93M formulation (Reeves 1997). Starting at two months of age, mice were maintained on the Control diet or were fed one of the following two test diets (n=10 mice per group): supplemented with fish oil (FO: 18/12 cholesterol-reduced fish oil, GC Rieber Oil AS, Kristiansund, Norway) or supplemented with SuperbaTM Krill Oil (KO, Aker BioMarine ASA, Norway). Both test diets were based on modifications of the Control diet and were formulated by substituting the soybean oil (4% in the Control diet) with either 1.1% fish oil or 1.5% krill oil. Fish and krill oil diets did not differ considerably in the total amount of ω-3 PUFAs as the content of EPA and DHA in the diets were 0.31% (fish oil diet) and 0.29% (krill oil diet). All diets were formulated by Bio-Serv (Frenchtown NJ, USA).

tag: strain

value: CBA/J


title: PD_brain_FCX_rep3

value: frontal cortex

value: Parkinson's disease

value: IPD 3


title: Liver_KrillOil_rep5

description: Mouse fed diet containing krill oil

source_name: Liver, KrillOil, rep5


title: Liver_KrillOil_rep6

description: Mouse fed diet containing krill oil

source_name: Liver, KrillOil, rep6


title: Control_brain_FCX_rep15

source_name: Brain tissue (frontal cortex), control

value: control

value: female

value: Control 21


title: Liver_KrillOil_rep2

description: Mouse fed diet containing krill oil

source_name: Liver, KrillOil, rep2

value: male


title: Liver_KrillOil_rep4

description: Mouse fed diet containing krill oil

source_name: Liver, KrillOil, rep4


title: Control_brain_FCX_rep14

value: Control 20


title: PD_brain_FCX_rep1

value: IPD 1


title: Liver_FishOil_rep7

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep7


title: CPT 15 h

first: Jennifer

last: Barb

address: 12 South Drive Bldg 12A Room 2001

department: DCB

description: HCT116 cells treated with 10 μM CPT during 15 h

hyb_protocol: Standard methods following recommendations of the manufacturer were used to hybridize the samples to the SpliceArrays. The arrays were washed and stained using the FS450-0001 Fluidics protocol.

scan_protocol: The scanning was done using the Affymetrix GeneChip® Scanner 3000 7G.

data_processing: The probe level normalization using RMA was done using Partek Genomics Suite v6.08 and the summarization of the probes was done on R 2.11.1.

label_protocol: Sample amplification and labeling was performed using the WT-Ovation Pico RNA  Amplification System and the FL-Ovation cDNA Biotin Module v2 (NuGen, Inc., part # 's 3300-60 and 4200-60) according to manufacturer's instructions.

growth_protocol: Human HCT116 cell line was obtained from ATCC (Rockville, MD) and grown in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Gemini Bio-products, West Sacramento, CA) at 37 degrees Celsius in 95% air and 5% CO2.

extract_protocol: RNA extraction was performed with the “Nucleospin RNA II” kit (Macherey-Nagel, Bethlehem, PA).

treatment_protocol: HCT116 cells were treated with CPT for 1, 2, 4, 15 and 20 hours. Controls samples were analyzed at 4 and 20 h following DMSO treatment (0.1%; the solvent used to dissolve CPT).

value: colon carcinoma cells

tag: cell line

tag: treatment group

value: treated with 10 μM CPT during 15 h


title: PD_brain_FCX_rep2

value: IPD 2


title: Liver_KrillOil_rep1

description: Mouse fed diet containing krill oil

source_name: Liver, KrillOil, rep1


title: Liver_FishOil_rep6

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep6


title: Liver_KrillOil_rep3

description: Mouse fed diet containing krill oil

source_name: Liver, KrillOil, rep3


title: Control_brain_FCX_rep12

value: Control 17


title: Group D, replicate 3

city: Barcelona

first: Carlos

middle: J

last: Ciudad

state: Barcelona

address: Av. Juan XXIII-27

department: Biochemistry and Molecular Biology

country: Spain

institute: University of Barcelona

description: Gene expression profile of mesenteric lymph nodes of pups from dams fed standard diet throughout the study.

hyb_protocol: Affymetrix protocol for Rat Genome 230 2.0

data_processing: GeneSpring GX software package v10.0.2. Value generated using MAS 5.0 non-scaled.

organism: Rattus norvegicus

source_name: Mesenteric lymph nodes, standard diet

extract_protocol: RNAeasy Lipid Tissue Mini kit from Qiagen

value: Wistar

value: mesenteric lymph nodes

tag: diet

value: standard during gestation and suckling period

tag: sample type

value: reference


title: Group D, replicate 2

scan_protocol: Affymetrix protocol for Rat Genome 230 2.0


title: Control_brain_FCX_rep10

value: brain

value: frontal cortex

value: Control 15


title: CPT 20 h

description: HCT116 cells treated with 10 μM CPT during 20 h

value: treated with 10 μM CPT during 20 h


title: CPT 2 h

description: HCT116 cells treated with 10 μM CPT during 2 h

value: treated with 10 μM CPT during 2 h


title: BrdU 25 mM HU rad53 sac3D

type: genomic

city: Milano

first: Andrea

last: Cocito

state: MI

address: Via Adamello 16

department: Molecular Medicine Program

country: Italy

institute: IFOM Institute FIRC  of Molecular Oncology

description: rad53 sac3-BrdU

hyb_protocol: Labelled probes were hybridized to Affymetrix S.cerevisiae whole genome tiling R arrays

scan_protocol: Arrays were scanned on an Affymetrix Scanner

data_processing: BAR files were produced with Tiling Array Suite 1.1 from the command line with these options: tilecore -analysis -bpmap Sc03b_MR_v04.bpmap -type 1 -n 1 -nt 1 -export 1 -output_type 0 -format_type 1 -band 150 -pval_scale 0 -sig_scale 2 -tail_type 1 -nscale 1 -tgt 500 [files]

molecule: genomic DNA

organism: Saccharomyces cerevisiae

source_name: IP fraction of CY9662 HU

label_protocol: Labeling and hybridization were carried out following the Affymetrix GeneChip Expression Anaysis protocol.

growth_protocol: Cells were grown in YPD.

extract_protocol: Extracton was performed as described in Katou et al., 2003.

treatment_protocol: G1 synchronization was performed by α−factor treatment (2 μg/ml), S  release was performed in 25 mM HU for 1 hour

source_name: SUP fraction of CY9662 HU


title: Liver_FishOil_rep5

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep5

value: CBA/J


title: Control_brain_FCX_rep9

value: control

value: male

value: Control 12


title: Control_brain_FCX_rep13

value: female

value: Control 19


title: CPT 1 h

description: HCT116 cells treated with 10 μM CPT during 1 h

value: colon carcinoma cells

value: treated with 10 μM CPT during 1 h


title: Liver_FishOil_rep2

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep2


title: CPT 4 h

description: HCT116 cells treated with 10 μM CPT during 4 h

value: treated with 10 μM CPT during 4 h


title: Control_brain_FCX_rep7

value: Control 10


title: Control_brain_FCX_rep11

value: Control 16


title: Control_brain_FCX_rep8

value: Control 11


title: Liver_FishOil_rep4

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep4


title: Group C, replicate 3

description: Gene expression profile of mesenteric lymph nodes of pups from dams fed standard diet during gestation and suckling and receiving CLA by daily oral gavage throughout the suckling period.

source_name: Mesenteric lymph nodes, CLA supplement

label_protocol: Affymetrix protocol for Rat Genome 230 2.0

value: Wistar

value: mesenteric lymph nodes

value: standard during gestation and CLA supplement during suckling period


title: Control_brain_FCX_rep6

value: brain

value: frontal cortex

value: Control 9


title: BrdU 25 mM HU rad53

source_name: IP fraction of CY9661 HU

source_name: SUP fraction of CY9661 HU


title: Liver_Control_rep7

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep7

value: CBA/J


title: BrdU 25 mM HU sac3D

source_name: IP fraction of CY9660 HU

source_name: SUP fraction of CY9660 HU


title: Liver_FishOil_rep3

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep3

value: male


title: Control_brain_FCX_rep5

source_name: Brain tissue (frontal cortex), control

value: control

value: Control 8


title: control DMSO 4 h

description: HCT116 cells treated with 0.1% DMSO during 4 h

value: treated with 0.1% DMSO during 4 h


title: Liver_FishOil_rep1

description: Mouse fed diet containing fish oil

source_name: Liver, FishOil, rep1


title: Liver_Control_rep5

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep5


title: Group B, replicate 3

description: Gene expression profile of mesenteric lymph nodes of pups from dams fed during gestation 1% CLA diet and CLA-supplemented daily by oral gavage during the suckling period.

source_name: Mesenteric lymph nodes, CLA from dam and CLA supplement

value: 1% conjugated linoleic acid (CLA) from dam during gestation and CLA supplement during suckling period


title: Liver_Control_rep6

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep6


title: Group C, replicate 1


title: Group C, replicate 2


title: control DMSO 20 h

description: HCT116 cells treated with 0.1% DMSO during 20 h

value: colon carcinoma cells

value: treated with 0.1% DMSO during 20 h


title: BrdU 25 mM HU WT

description: WT-BrdU

source_name: IP fraction of SY2201 HU

source_name: SUP fraction of SY2201 HU


title: PD_brain_FCX_rep4

source_name: Brain tissue (frontal cortex), PD

value: Parkinson's disease

value: female

value: IPD 4


title: Control_brain_FCX_rep4

value: Control 7


title: Group B, replicate 2

value: Wistar

value: mesenteric lymph nodes


title: normal FVB pregnant M1_4

status: Public on Jul 21 2011

first: Jeffrey

middle: E

last: Green

address: Rm 4054, 37 Convent Drive

institute: NCI

description: normal FVB pregnant mammary tissue, replicate 4

hyb_protocol: The labeled RNA was subsequently used for hybridization onto the LMT_mouse miRNA_v2 microarrays without the need for column purification.

scan_protocol: Scanned using the Agilent scanner.

data_processing: The gProcessSignal values of probes designed for mouse miRNAs were feature extracted using the GE2 protocol (www.agilent.com) with exclusion of internal control probes, non-mouse probes, and all negative strand probes. A global median normalization procedure was applied to the gProcessSignal values of the selected probes across all arrays.

source_name: female mouse normal mammary tissues

label_protocol: 1 µg of total RNA containing the microRNAs were labeled using the miRCURY ™ LNA microRNA Array Labeling kit (Exiqon). The 3’-end of the total RNA was enzymatically labeled with the Hy3 and/or Hy5 fluorescent dye (Exiqon) by incubating with T4 RNA ligase at 0oC for 1 hour followed by an enzyme inactivation step of 65oC for 15 minutes.

extract_protocol: The total RNA containing the microRNA species were extracted from tumor and tissue samples using mirVana miRNA Isolation kit (Ambion).

value: FVB


title: Control_Steady_rep1

source_name: Endothelial cell, Control, Steady Shear

value: Porcine Aortic Endothelial Cells

source_name: Reference, Endothelial Cells, Static


title: Control_brain_FCX_rep1

value: brain

value: frontal cortex

value: Control 1


title: normal FVB pregnant M1_3

description: normal FVB pregnant mammary tissue, replicate 3


title: Liver_Control_rep4

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep4

value: CBA/J

value: male


title: Group A, replicate 3

description: Gene expression profile of mesenteric lymph nodes of pups from dams fed with 1% CLA diet during the two weeks of gestation and throughout the suckling period.

source_name: Mesenteric lymph nodes, CLA from dam

value: 1% conjugated linoleic acid (CLA) from dam during gestation and suckling period


title: male thorax 1-4

city: Bloomington

first: Colin

middle: D

last: Meiklejohn

state: IN

address: Jordan Hall, 1001 E. 3rd St.

department: Biology Department

institute: Indiana University

hyb_protocol: 825ng per sample of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was fragmented at 60°C for 30 minutes in a reaction volume of 55 ul containing 11ul 25x Agilent fragmentation buffer and 2.2 ul 10x Agilent blocking agent following the manufacturers instructions. On completion of the fragmentation reaction, 55 ul of 2x Agilent hybridization buffer was added to the fragmentation mixture and hybridized 100ul to Agilent Drosophila Gene Expression Microarrays (G2519F) for 17 hours at 65°C in a rotating Agilent hybridization oven. After hybridization, microarrays were washed 1 minute at room temperature with GE Wash Buffer 1 (Agilent) and 1 minute with 37°C GE Wash buffer 2 (Agilent), then dried immediately by brief centrifugation.

scan_protocol: Slides were scanned immediately after washing on an Agilent DNA Microarray Scanner (G2505B) using one color scan setting for 4x44k array slides (Scan Area 61x21.6 mm, Scan resolution 5um, Dye channel was set to Red & Green and both the Red and Green PMT were set to 100%).

data_processing:
The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using parameters (protocol GE1-105_DEC8 and Grid: 012391_D_20060331) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.
Log2 expression values for the three tissues profiled in this study. Expression estimates were obtained from 4 replicate arrays per tissue, using the lmFit function in the limma package for R.

organism: Drosophila melanogaster

source_name: cells dissected from adult male thorax

label_protocol: 1 microgram of extracted RNA was used as a template for cRNA synthesis using Ambion's Amino Allyl MessageAmp aRNA protocol

growth_protocol: Wild-type flies of the OreR lab strain were raised on standard cornmeal media at room temperature

extract_protocol: RNA was extracted using the Clonetech Nucleospin RNA kit including a Dnase treatment

treatment_protocol: Testis apical tips were dissected in Ringer's solution with the surrounding testis sheath removed. Thoraxes were dissected in Ringer's solution away from the head and abdomen and the legs and wings were removed

value: thorax

tag: Sex


title: Liver_Control_rep2

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep2


title: testis apical tip 1-4

description: Expression estimates were obtained from 4 replicate arrays per tissue

source_name: cells dissected from the apical tip of the testis

value: testis apical tip


title: Liver_Control_rep3

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep3


title: normal FVB pregnant M1_2

description: normal FVB pregnant mammary tissue, replicate 2


title: Control_brain_FCX_rep2

source_name: Brain tissue (frontal cortex), control

value: control

value: Control 2


title: MMTV-PymT 5-1

description: MMTV-PymT mammary tumor, replicate 4

source_name: female mouse primary mammary tumor


title: MMTV-PymT 437

description: MMTV-PymT mammary tumor, replicate 6


title: MMTV-PymT 436

description: MMTV-PymT mammary tumor, replicate 5


title: normal FVB pregnant M1_1

description: normal FVB pregnant mammary tissue, replicate 1


title: Group B, replicate 1

value: 1% conjugated linoleic acid (CLA) from dam during gestation and CLA supplement during suckling period


title: Liver_Control_rep1

description: Mouse fed AIN93M Control diet

source_name: Liver, Control, rep1


title: MMTV-PymT 11568

description: MMTV-PymT mammary tumor, replicate 2


title: MMTV-PymT 11570

description: MMTV-PymT mammary tumor, replicate 3


title: MMTV-PymT 11567

description: MMTV-PymT mammary tumor, replicate 1


title: Group A, replicate 2


title: Group A, replicate 1


title: female thorax 1-4

source_name: cells dissected from adult female thorax

value: female


title: Control_brain_FCX_rep3

value: Control 3


title: normal FVB pregnant M1_5

description: normal FVB pregnant mammary tissue, replicate 5


title: Brca1-/-p53+/- 53447

description: Brca1-/-p53+/- mammary tumor, replicate 5


title: Brca1-/-p53+/- 572

description: Brca1-/-p53+/- mammary tumor, replicate 3


title: Brca1-/-p53+/- 627

description: Brca1-/-p53+/- mammary tumor, replicate 4


title: Brca1-/-p53+/- 4176

description: Brca1-/-p53+/- mammary tumor, replicate 1


title: MMTV-Wnt 4676

description: MMTV-Wnt mammary tumor, replicate 2


title: MMTV-Wnt 4677

description: MMTV-Wnt mammary tumor, replicate 4


title: MMTV-Wnt 4635

description: MMTV-Wnt mammary tumor, replicate 3


title: MMTV-Wnt 4675

description: MMTV-Wnt mammary tumor, replicate 1


title: MMTV-Hras 2-4

description: MMTV-Hras mammary tumor, replicate 5


title: p53-/- 2979

description: p53-/- mammary tumor, replicate 1

value: Balb/C


title: Brca1-/-p53+/- 503

description: Brca1-/-p53+/- mammary tumor, replicate 2


title: MMTV-Hras 4-4

description: MMTV-Hras mammary tumor, replicate 4


title: MMTV-Hras 3-4

description: MMTV-Hras mammary tumor, replicate 2


title: p53-/- 5809

description: p53-/- mammary tumor, replicate 2


title: p53-/- 5354

description: p53-/- mammary tumor, replicate 7


title: p53-/- 5817

description: p53-/- mammary tumor, replicate 3


title: p53-/- 1570

description: p53-/- mammary tumor, replicate 6


title: p53-/- 5851

description: p53-/- mammary tumor, replicate 4


title: p53-/- 8546

description: p53-/- mammary tumor, replicate 5


title: FVB pregnant 5

description: Gene expression data of mouse normal mammary glands

hyb_protocol: cRNA were hybridized onto GeneChip Mouse Genome 430A 2.0 Array.

scan_protocol: GeneChips were scanned using the Affymetrix GeneChip scanner 3000.

data_processing: Data were collected using Affymetrix GCOS software and then normalized using GC-RMA of Partek Genomic Suite (www.partek.com). The normalized data was further filtered using MAS5 detection calls for probes designated as “P” (present) or “M” (Marginal) in less than 3 samples of all data population.

label_protocol: Biotinylated cRNA from 1 ug total RNA were prepared using Affymetrix One Cycle Target Labeling kit.

extract_protocol: Total RNA was extracted from tumor and normal tissues using the mirVana miRNA Isolation kit (Ambion) according to the manufacturer's instructions.

tag: tissue type

value: normal mammary


title: FVB pregnant 3

value: FVB


title: FVB pregnant 2


title: MMTV-PymT 4

description: Gene expression data of mouse primary mammary tumors

tag: genetically engineered mouse model

value: MMTV-PymT

value: mammary tumor


title: FVB pregnant 1


title: MMTV-PymT 3


title: Brca1-/-p53+/- 5


title: MMTV-PymT 5


title: MMTV-PymT 1


title: MMTV-H2N 64

description: MMTV-H2N mammary tumor, replicate 5


title: FVB pregnant 4


title: MMTV-PymT 6


title: MMTV-PymT 2


title: MMTV-Hras 5-4

description: MMTV-Hras mammary tumor, replicate 3


title: Brca1-/-p53+/- 2


title: MMTV-H2N 1

description: MMTV-H2N mammary tumor, replicate 3


title: MMTV-C-Myc 04005648

description: MMTV-C-Myc mammary tumor, replicate 3


title: Brca1-/-p53+/- 1


title: MMTV-C-Myc 04004021B

description: MMTV-C-Myc mammary tumor, replicate 4


title: MMTV-H2N A

description: MMTV-H2N mammary tumor, replicate 1


title: MMTV-H2N 61

description: MMTV-H2N mammary tumor, replicate 4


title: MMTV-Hras 1-4

description: MMTV-Hras mammary tumor, replicate 1


title: C3TAg 7 2

description: C3TAg mammary tumor, replicate 4


title: MMTV-H2N 53

description: MMTV-H2N mammary tumor, replicate 2


title: MMTV-C-Myc 043508

description: MMTV-C-Myc mammary tumor, replicate 1


title: C3TAg 5

description: C3TAg mammary tumor, replicate 3


title: C3TAg_8

description: C3TAg mammary tumor, replicate 5


title: C3TAg 4

description: C3TAg mammary tumor, replicate 2


title: MMTV-Wnt 3

value: MMTV-Wnt


title: p53-/- 7


title: p53-/- 2


title: MMTV-C-Myc 04004022

description: MMTV-C-Myc mammary tumor, replicate 2


title: MMTV-Wnt 2


title: MMTV-Wnt 4


title: C3TAg 2

description: C3TAg mammary tumor, replicate 1


title: p53-/- 6


title: p53-/- 3


title: FVB M4

description: normal mammary tissue from mouse strain FVB, replicate 2

source_name: female mouse normal mammary tissue


title: p53-/- 5


title: MMTV-Wnt 1


title: MMTV-Hras 5

value: MMTV-Hras


title: p53-/- 1


title: Balbc M2_2R

description: normal mammary tissue from mouse strain Balbc, replicate 3

value: Balbc


title: FVB M2

description: normal mammary tissue from mouse strain FVB, replicate 1


title: p53-/- 4


title: Brca1-/-p53+/- 4


title: MMTV-Hras 3


title: Balbc M1_2L

description: normal mammary tissue from mouse strain Balbc, replicate 1


title: Balbc M2_2L

description: normal mammary tissue from mouse strain Balbc, replicate 2


title: FVB129B6 23

description: normal mammary tissue from mouse strain FVB129B6, replicate 3


title: FVB129B6 22

description: normal mammary tissue from mouse strain FVB129B6, replicate 2


title: Brca1-/-p53+/- 3


title: MMTV-H2N 5


title: C3TAg 8

description: C3TAg mammary tumor, replicate 3


title: C3TAg 7

description: C3TAg mammary tumor, replicate 2


title: FVB129B6 21

description: normal mammary tissue from mouse strain FVB129B6, replicate 1


title: C3TAg 2_

description: C3TAg mammary tumor, replicate 1


title: MMTV-Hras 2


title: MMTV-H2N 4


title: MMTV-Hras 1


title: MMTV-C-Myc 3

value: MMTV-C-Myc


title: Group D, replicate 1

description: Gene expression profile of mesenteric lymph nodes of pups from dams fed standard diet throughout the study.

source_name: Mesenteric lymph nodes, standard diet

value: Wistar

tag: tissue

value: mesenteric lymph nodes

value: standard during gestation and suckling period

value: reference


title: MMTV-H2N 1


title: MMTV-H2N 3


title: MMTV-C-Myc 4


title: MMTV-Hras 4


title: MMTV-C-Myc 2


title: C3TAg 5


title: Δcre-1 Avicel-4h vs. Δcre-1 MM-4h

city: Berkeley

first: Jianping

last: Sun

address: 111 Koshland Hall

institute: UC Berkeley

description:
13990849
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.

hyb_protocol: The Pronto! Hybridization Kit (Corning, catalog no. 40076) was used for microarray hybridization according to the manufacturer’s specifications.

scan_protocol: Scanned on a GenePix 4000B scanner (Axon Instruments).

data_processing: GenePix Pro6 software was used to quantify hybridization signals and collect the raw data. Normalized expression values were analyzed by using BAGEL (Bayesian Analysis of Gene Expression Levels; PMID 12537560).

organism: Neurospora crassa

source_name: Δcre-1 transferred to Avicel for 4h from a 16h MM culture

label_protocol: 10 µg of total RNA were used. The ChipShot Indirect Labeling/Clean-Up System (Promega, catalog no. Z4000) and CyDye Post-Labeling Reactive Dye Pack (GE, catalog no. RPN5661) were used to synthesize and label cDNA according to the manufacturer’s instructions.

growth_protocol: N. crassa was pregrown in minimal medium (MM) for 16h at 25C.

extract_protocol: Total RNA was extracted using Trizol following the manufacturer's instructions.

treatment_protocol: The pregrown hyphae were washed by 1x Vogel's media and then transferred into either MM or Avicel (Avi) for 4h.

tag: genotype

tag: growth condition

value: Avicel

source_name: Δcre-1 transferred to MM for 4h from a 16h MM culture

value: minimal medium (MM)


title: WT MM-4h vs. WT Avicel-4h

description:
13926725
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.

source_name: wildtype (WT) transferred to MM for 4h from a 16h MM culture

value: FGSC 2489

value: WT

source_name: wildtype (WT) transferred to Avicel for 4h from a 16h MM culture


title: Δcre-1 MM-4h vs. Δcre-1 Avicel-4h

description:
13990847
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.


title: Δcre-1 MM-4h vs. WT MM-4h

description:
13990625
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.


title: MMTV-C-Myc 1


title: WT MM-4h vs. Δcre-1 MM-4h

description:
13927387
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.


title: L3 genital imaginal disc - Canton S - replicate 4

city: Los Angeles

first: Justin

last: Dalton

address: 1050 Child's Way, RRI

department: Biological Sciences

institute: University of Southern California

description: Biological replicate 4 of 5: Canton S female third larval instar genital imaginal disc to Canton S male third larval instar genital imaginal disc

hyb_protocol: Amplified cRNA samples were then dried and resuspended in formamide (56%), sodium citrate buffer (SSC, 3.37×), SDS (1.12%), Denhardts (5.62×), and Polyadenylic acid potassium salt (0.9 mg/ml; Sigma-Aldrich, St. Louis, MO). Samples were boiled for 2 minutes and then applied to microarray slides underneath a LifterSlip (Erie Scientific, Portsmouth, PA). Microarrays were hybridized at 42◦C for 14-18 hours, then washed in a solution of 1.5% SDS and 1X SSC for 5 minutes, a solution of 0.20X SSC for 5 minutes, and two solutions of 0.05X SSC for 10 minutes each.

scan_protocol: All arrays were scanned using the GenePix 4100A scanner and GenePix Pro 5.0 software from Axon Instruments (Molecular Diagnostics, Sunnyvale, CA).

data_processing: Visual inspection of the microarray images filtered out florescence most likely not due to labeled cDNA binding; the data from these array elements was discarded. Array elements were only considered for further analysis if at least one channel (Cy3 or Cy5) had greater than 75% of the pixels with intensity values one standard deviation above background levels. All microarray normalization and statistical analyses were performed using the limma package of BioConductor in the program R.

source_name: Canton S Female

label_protocol: cRNA probes were made from poly(A)+ transcripts derived from genital imaginal disc tissue using the Amino Allyl MessageAmp II aRNA Amplification Kit (Ambion). Ten micrograms of amplified cRNA was then labeled with either Cy5 or Cy3 fluorescent dye (Amersham Bioscience). The cRNA samples were then purified (Gel-Purification Kit, Qiagen, Valencia, CA).

growth_protocol: Flies were raised at 25°C under a 12-hour light:dark cycle, on standard cornmeal, yeast, dextrose media. Adult females, either Berlin or Canton S, were allowed to ovposit on medium supplemented with 0.05% bromophenol blue to allow visualization of gut clearing after the high-titre ecdysone pulse during late third larval instar stage of development. This allowed us to harvest genital discs and assay gene expression during a narrow window of development (~2-5 hours).

extract_protocol: Total RNA was extracted from ~50-100 third larval instar genital discs homogenized in TRIzol® and extraction using the TRIzol® protocol (Invitrogen, Carlsbad, CA).

treatment_protocol: Larvae were dissected post gut clearing in ice cold RNAse-free 1X PBS and genital imaginal discs transfered immediately to TRIzol® reagent (Invitrogen) and homogenized.

value: Canton S

tag: gender

value: Female

tag: Stage

value: Third larval instar

value: Genital imaginal disc

tag: treatment

value: Dissected post-gut clearing

source_name: Canton S Male

value: Male


title: C3TAg 3

value: mammary tumor

value: FVB


title: Δcre-1 Avicel-4h vs. WT Avicel-4h

description:
13926729
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.


title: L3 genital imaginal disc - Canton S - replicate 5

description: Biological replicate 5 of 5: Canton S female third larval instar genital imaginal disc to Canton S male third larval instar genital imaginal disc


title: C3TAg 4

description: Gene expression data of mouse primary mammary tumors


title: L3 genital imaginal disc - Canton S - replicate 2

description: Biological replicate 2 of 5: Canton S female third larval instar genital imaginal disc to Canton S male third larval instar genital imaginal disc


title: L3 genital imaginal disc - Canton S - replicate 3

description: Biological replicate 3 of 5: Canton S female third larval instar genital imaginal disc to Canton S male third larval instar genital imaginal disc


title: WT Avicel-4h vs. WT MM-4h

description:
13926726
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.


title: MMTV-H2N 2


title: HZ30, rep3

city: Hershey

first: Penn State

last: COM

state: PA

address: 500 University Drive

department: Genome Sciences Facility

institute: Penn State College of Medicine

description:
5298408027_K
Replicate 3 of 4.

data_processing: The data were normalized using quantile normalization in GenomeStudio v2010.2.

label: Biotin

source_name: hippocampus, dw HZ, saline, 30 days

label_protocol: Biotinylated cRNA were prepared with the Ambion TotalPrep kit for Illumina arrays.  Cy3-Streptavidin was incorporated during the Wash and Block protocol as a fluor for scanning.

extract_protocol: RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with the QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with the Agilent Bioanalyzer.

value: HsdOla:DWARF-dw-4 HZ

value: hippocampus

tag: age

value: 65 days

value: saline

tag: treatment duration

value: 30 days

value: control


title: C3TAg 1


title: HZ30, rep4

description:
5298408027_L
Replicate 4 of 4.


title: dw/dw+GH30, rep4

description:
5298408027_H
Replicate 4 of 4.

source_name: hippocampus, dw/dw, GH, 30 days

value: growth hormone (GH)


title: HZ30, rep2

description:
5298408027_J
Replicate 2 of 4.


title: HZ30, rep1

description:
5298408027_I
Replicate 1 of 4.


title: dw/dw+GH30, rep2

description:
5298408027_F
Replicate 2 of 4.


title: dw/dw+GH30, rep1

description:
5298408027_E
Replicate 1 of 4.


title: WT Avicel-4h vs. Δcre-1 Avicel-4h

description:
13926728
N. crassa was pregrown in MM for 16h at 25C, and then transferred into either MM or Avicel for 4h.

value: FGSC 2489

value: Avicel


title: dw/dw+GH30, rep3

description:
5298408027_G
Replicate 3 of 4.


title: L3 genital imaginal disc - Berlin - replicate 5

description: Biological replicate 5 of 5: Berlin female third larval instar genital imaginal disc to Berlin male third larval instar genital imaginal disc

source_name: Berlin Female

value: Berlin

source_name: Berlin Male


title: L3 genital imaginal disc - Canton S - replicate 1

description: Biological replicate 1 of 5: Canton S female third larval instar genital imaginal disc to Canton S male third larval instar genital imaginal disc

value: Canton S

value: Female


title: L3 genital imaginal disc - Berlin - replicate 3

description: Biological replicate 3 of 5: Berlin female third larval instar genital imaginal disc to Berlin male third larval instar genital imaginal disc

value: Third larval instar

value: Genital imaginal disc


title: C3TAg 2


title: L3 genital imaginal disc - Berlin - replicate 2

description: Biological replicate 2 of 5: Berlin female third larval instar genital imaginal disc to Berlin male third larval instar genital imaginal disc

value: Dissected post-gut clearing

value: Male


title: L3 genital imaginal disc - Berlin - replicate 4

description: Biological replicate 4 of 5: Berlin female third larval instar genital imaginal disc to Berlin male third larval instar genital imaginal disc


title: L3 genital imaginal disc - Berlin - replicate 1

description: Biological replicate 1 of 5: Berlin female third larval instar genital imaginal disc to Berlin male third larval instar genital imaginal disc


title: Fmr1 KO P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 3

city: New York

first: Chaolin

last: Zhang

state: NY

address: 1230 York Ave

department: Molecular Neuro-Oncology

institute: Rockefeller University

hyb_protocol: Hybridization of the biotin-labelled cRNA to MG430 2.0 GeneChips (Affymetrix) was conducted by the Rockefeller University Genomics Resource Center (http://www.rockefeller.edu/genomics/).

scan_protocol: The scanning and image acquisition was done using Affymetrix GeneChip Operating Software (GCOS) v1.3. The scanner model is GeneChip Scanner 3000.

data_processing: The raw CEL files were processed by gcRMA in Bioconductor using parameters type=fullmodel and fast=F

label_protocol: Total cytoplasmic or polyribosomal RNA was isolated with TriZol LS (Invitrogen) extraction followed by RNAEasy (Qiagen) purification with DNAse treatment on-column. RNA integrity was checked by running the RNA samples on an Agilent 2100 Bioanalyzer and quantified by Nanodrop. Ten micrograms of RNA was used as input for cRNA generation according to Affymetrix guidelines.  Biotin-labelled, fragmented cRNA was prepared by standard methods at the Rockefeller University Genomics Resource Center.  Both the labeling of cRNA and probing of MG430 2.0 GeneChips (Affymetrix) was conducted by the Rockefeller University Genomics Resource Center (http://www.rockefeller.edu/genomics/).

extract_protocol: Polyribosomes from cerebral cortices of P7 male WT and paired Fmr1 null littermate mice (FVB background) were prepared as follows. The mice were sacrificed by isoflurane anaesthesia and decapitation, and brains transferred to ice-cold HEPES-buffered Hank’s balanced salt solution containing 0.1 mg/ml cycloheximide (CHX), on ice. The cerebral cortex was dissected out and white matter carefully removed.  Cortices were each transferred to 1 ml lysis buffer (10 mM HEPES-KOH, pH 7.4, 150 mM KCl, 5 mM MgCl2, 0.5mM dithiothreitol, 0.1 mg/ml CHX, 1X Complete EDTA-free protease inhibitor cocktail (Roche), 40 U/ml rRNAsin (Promega)) and homogenized in a Teflon-glass homogenizer.  NP-40 was added to 1% final concentration and samples allowed to rest on ice for 10-20 minutes.  The lysate was then spun at 2000 x g for 10 minutes in microfuge tubes, resulting S1 transferred to a new microfuge tube and spun at 20,000 x g for 10 min to make S2. 1 ml of S2 was loaded on 20-50% (w/w) linear sucrose gradients prepared in gradient buffer (10 mM HEPES-KOH, pH 7.4, 150 mM KCl, 5 mM MgCl2) and spun at 40,000 rpm for 2 hours in a Beckman SW41 rotor. Sixteen fractions of 0.72 ml were collected with monitoring of the A254 trace (ISCO system).  Two mice of each genotype were pooled per polysome gradient. Six biological replicates from each genotype were prepared.  20% of the total S2 was reserved for total RNA “input” before application to the gradients. Following fractionation 15% of each fraction was analyzed by Western blot and RNA was extracted from the remaining 85% of each fraction using Trizol LS.  RNA from fractions 10-13, corresponding to association with 6 or more ribosomes, was pooled as polyribosomal RNA.  Both total and polyribosomal RNAs were labeled by standard methods and used to interrogate Affymetrix Mouse 430 2.0 GeneChips.

treatment_protocol: Mice were maintained in the Rockefeller University Comparative Bioscience Center until use, and their care was compliant with the Guide for the Care and Use of Laboratory Animals as described by the National Research Council. The Comparative Bioscience Center (CBC) is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. These studies were performed with IACUC approval.

value: FVB

value: male

tag: genotype/variation

value: Fmr1 KO

value: cerebral cortex

tag: rna source

value: total lysate RNA


title: HZ7, rep3

description:
5298408026_K
Replicate 3 of 4.

source_name: hippocampus, dw HZ, saline, 7 days

tag: strain

value: HsdOla:DWARF-dw-4 HZ

value: hippocampus

value: 42 days

value: saline

value: 7 days


title: Fmr1 KO P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 4


title: Fmr1 KO P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 5


title: Fmr1 KO P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 6


title: WT brain polysome 1

description:
WT1
mouse wild type brain
total RNA less some rRNA by RiboMinus kit

hyb_protocol: Affymetrix WT Sense Target Labeling Assay

scan_protocol: The scanning and image acquisition was done using Affymetrix GeneChip Operating Software (GCOS) v1.4. The scanner model is GeneChip Scanner 3000 7G.

data_processing:
Affymetrix Power Tools; PLIER/IterPLIER model
probe group file: MoEx-1_0-st-v1.r2.pgf
meta-probeset file: MoEx-1_0-st-v1.r2.dt1.mm8.extended.mps

source_name: male P25 FVB mouse whole brain less the major white matter tracts

extract_protocol: Trizol Extraction; RiboMinus kit.

value: WT

value: whole brain (less the major white matter tracts)

value: purified polyribosomal fractions


title: WT brain polysome 2

description:
WT2
mouse wild type brain
total RNA less some rRNA by RiboMinus kit

label_protocol: Affymetrix WT Sense Target Labeling Assay


title: dw/dw+sal30, rep4

description:
5298408027_D
Replicate 4 of 4.

source_name: hippocampus, dw/dw, saline, 30 days

value: 65 days

value: 30 days


title: HZ7, rep2

description:
5298408026_J
Replicate 2 of 4.

value: control


title: dw/dw+sal30, rep3

description:
5298408027_C
Replicate 3 of 4.


title: WT P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 6


title: HZ7, rep4

description:
5298408026_L
Replicate 4 of 4.


title: dw/dw+sal30, rep2

description:
5298408027_B
Replicate 2 of 4.


title: Fmr1 KO P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 2


title: TNF treated fibrin culture, biological rep3

city: Seattle

first: Alfred

middle: C

last: Aplin

state: WA

address: Box 357470 HSB-UW

department: Pathology

institute: University of Washington

description: Gene expression in TNF treated fibrin gel cultures of rat aorta at day 2

hyb_protocol: Following fragmentation, 10ug of cRNA was hybridized for 17 hr at 45 degrees C on Affymetrix Rat Gene 1.0 ST Arrays. GeneChips were washed and stained in the Affymetrix Gene Chip Fluidics Station 450.)

scan_protocol: Affymetrix Rat Gene 1.0 ST Arrays were scanned using the Affymetrix GeneChip® 3000 scanner.

data_processing: Raw microarray data were processed with Bioconductor (http://www.bioconductor.org/) Probes were normalized with the Robust Multi-Array normalization procedure (Irizarry RA, Gautier L, Cope L, eds. An r package for analyses of affymetrix oligonucleotide arrays. London: Springer; 2003. Parmigiani RIG, Garrett ES, Zeger S, eds. The analysis of gene expression data: Methods and software.) From the normalized data, genes with significant evidence for differential expression were identified using the Bioconductor limma package (Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology. 2004;3:3)

source_name: TNF treated fibrin gel culture or aortic ring, day 2

label_protocol: Biotinylated cRNA was prepared according to standard Affymetrix Whole Transcript Sense Labeling Protocol from 200 ng of total RNA. (GeneChip® Whole Transcript (WT) Sense Target Labeling Assay User Manual, P/N 701880 Rev. 5)

growth_protocol: Four to six individual aortic ring cultures from each treatment groupd were combined to generate a sample.  All cultures were grown in serum free EBM medium (Lonza).  Samples were divided into treatment groups receiving 10ng/ml recombinant Rat TNFa or left untreated.

extract_protocol: Following pulverization under liquid nitrogen, extraction of total RNA was performed with a microRNA Easy kit from Qiagen according to the manufacturer's instructions.

treatment_protocol: Collagen or fibrin gels containing aortic rings were washed in PBS, transferred to buffer RLT from the Qiagen RNAEasy kit, and snap frozen in liquid nitrogen.

value: TNF treated fibrin

value: aortic rings cultured in collagen gels

value: Fisher 344

value: 1-2 month old rat aortas


title: TNF treated fibrin culture, biological rep2

value: male


title: HZ7, rep1

description:
5298408026_I
Replicate 1 of 4.


title: TNF treated fibrin culture, biological rep1


title: Fmr1 KO P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 1

value: FVB

value: Fmr1 KO

value: cerebral cortex

value: total lysate RNA


title: WT P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 5


title: dw/dw+GH7, rep3

description:
5298408026_G
Replicate 3 of 4.

source_name: hippocampus, dw/dw, GH, 7 days

value: hippocampus

value: 42 days

value: growth hormone (GH)


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 8)

city: Padova

first: Gerolamo

last: Lanfranchi

address: Via U. Bassi, 58/B

department: CRIBI - Biotechnology Center and Biology Department

institute: University of Padova

description: We compared the transcription profiles of a type 1 isolated myofibre by microarray competitive hybridization against a pool of soleus and EDL whole muscles.

hyb_protocol: Labeled RNAs were concentrated by ethanol precipitation and dissolved in 118μl of hybridization buffer (5XSSC, 0.1% SDS, 25% formamide). Labeled aRNA target from single fibre sample and whole muscle control were mixed before precipitation. After denaturation at 90°C for 2 min, the labeled targets were added to the microarrays, previously incubated in prehybridization buffer (5X SSC, 0.1% SDS,100ng/ul ss-DNA, 5X Denhardt) for ~ 20 hours at 46°C. Hybridization was carried for 44 hours at 46°C in an ArrayBooster microarray incubator (Advalytix), followed by a series of post-hybridization washings.

scan_protocol: Fluorescence detection was carried out on a VersArray ChipReader dual confocal laser scanner (Bio-Rad) at 6µm resolution, and raw scanner images were analyzed with QuantArray software (Perkin-Elmer).

data_processing: Normalization of the expression levels was performed with MIDAW tool (Romualdi et al., 2005 - Nucleic Acids Res. 33: W644-9).

source_name: EDL and soleus whole muscles mixture (reference)

label_protocol: Two rounds of linear amplification of mRNA from 100ng of total RNA was carried on using the Amino Allyl Message-Amp-aRNA kit (Ambion) according to the manufacturer’s recommendations. 5μg of aRNA from the sample was coupled to Cy3 dye (Amersham Pharmacia Biotech) to obtain labeled aRNA ready for microarray hybridization.

extract_protocol: Total RNA was purified from muscles following the standard Trizol protocol. The Nanodrop ND-1000 (Celbio) was used for RNA quantification and RNA 6000 Nano LabChip kit (Agilent Technologies) was used for RNA quality control in conjunction with an Agilent Bioanalyzer 2001.

value: 3 pairs of EDL and soleus whole muscle pooled from 3 wild-type CD1 mice

tag: myofiber type

value: balanced composition of type 1 and type 2B myofibres

source_name: Type 1 single myofibre isolated by enzymatic digestion (test)

label_protocol: Two rounds of linear amplification of mRNA from the total RNA extracted was carried on using the Amino Allyl Message-Amp-aRNA kit (Ambion) according to the manufacturer’s recommendations. 5μg of aRNA from the sample was coupled to Cy5 dye (Amersham Pharmacia Biotech) to obtain labeled aRNA ready for microarray hybridization.

extract_protocol: Total RNA was purified from the major part of fibre following the standard RNeasy Micro Kit (Qiagen) protocol.

value: Soleus whole muscle

value: type 1


title: dw/dw+GH7, rep2

description:
5298408026_F
Replicate 2 of 4.

hyb_protocol: Standard Illumina hybridization protocol.

scan_protocol: Standard Illumina scanning protocol.

value: 7 days


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 10)


title: Fibrin control culture, biological rep2

description: Gene expression in fibrin gel cultures of rat aorta at day 2

source_name: Fibrin gel culture of aortic ring, day 2

value: Fibrin control


title: WT P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 3

value: WT


title: dw/dw+sal30, rep1

description:
5298408027_A
Replicate 1 of 4.

value: 65 days

value: saline

value: 30 days


title: WT P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 4

value: FVB

value: male


title: WT P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 1

value: cerebral cortex


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 9)


title: Fibrin control culture, biological rep1

value: aortic rings cultured in collagen gels

value: Fisher 344

value: 1-2 month old rat aortas


title: TNF treated collagen culture, biological rep3

description: Gene expression in TNF treated collagen gel cultures or rat aorta at day 2

source_name: TNF treated collagen gel culture of aortic ring, day 2

value: TNF treated collagen


title: Fibrin control culture, biological rep3


title: Fmr1 KO P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 6

value: Fmr1 KO

value: purified polyribosomal fractions from a 20-50% sucrose gradient


title: dw/dw+GH7, rep1

description:
5298408026_E
Replicate 1 of 4.

value: hippocampus

value: 42 days

value: growth hormone (GH)


title: dw/dw+GH7, rep4

description:
5298408026_H
Replicate 4 of 4.

value: 7 days


title: dw/dw+sal7, rep4

description:
5298408026_D
Replicate 4 of 4.

source_name: hippocampus, dw/dw, saline, 7 days


title: dw/dw+sal7, rep3

description:
5298408026_C
Replicate 3 of 4.


title: WT P7 mouse cerebral cortex, total cortical lysate RNA, biological replicate 2

value: WT

value: total lysate RNA


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 7)

value: 3 pairs of EDL and soleus whole muscle pooled from 3 wild-type CD1 mice

value: balanced composition of type 1 and type 2B myofibres

value: Soleus whole muscle

value: type 1


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 5)


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 6)


title: dw/dw+sal7, rep2

description:
5298408026_B
Replicate 2 of 4.

value: saline


title: TNF treated collagen culture, biological rep2

value: aortic rings cultured in collagen gels

value: male


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 4)


title: Fmr1 KO P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 5

value: FVB

value: cerebral cortex


title: Collagen control culture, biological rep1

description: Gene expression in collagen gel cultures of rat aorta at day 2

source_name: Collagen gel culture of aortic ring, day 2

value: Collagen control

value: Fisher 344

value: 1-2 month old rat aortas


title: dw/dw+sal7, rep1

description:
5298408026_A
Replicate 1 of 4.

value: hippocampus

value: 42 days


title: Fmr1 KO P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 2

value: Fmr1 KO

value: purified polyribosomal fractions from a 20-50% sucrose gradient


title: Collagen control culture, biological rep3


title: WT P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 5

value: WT


title: Fmr1 KO P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 4


title: Day 1 culture, biological rep1

description: Gene expression data from day 1 aortic ring cultures

hyb_protocol: Following fragmentation, 10ug of cRNA was hybridized for 17 hr at 45 degrees C on Affymetrix Rat Gene 1.0 ST Arrays. GeneChips were washed and stained in the Affymetrix Gene Chip Fluidics Station 450.

source_name: Aortic ring culture at day 1

growth_protocol: Four to six individual aortic rings or ring cultures from each timepoint were combined to generate a sample.  Ring cultures were grown in serum free EBM medium (Lonza).

treatment_protocol: Freshly harvested aortic rings or collagen gels containing aortic rings were washed in PBS, transferred to buffer RLT from the Qiagen RNAEasy kit, and snap frozen in liquid nitrogen.

value: 1-2 month


title: TNF treated collagen culture, biological rep1

value: TNF treated collagen


title: Collagen control culture, biological rep2


title: Fmr1 KO P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 1


title: WT P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 6


title: Day 1 culture, biological rep3


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 3)

value: 3 pairs of EDL and soleus whole muscle pooled from 3 wild-type CD1 mice

value: balanced composition of type 1 and type 2B myofibres

value: Soleus whole muscle


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus1)

value: type 1


title: WT P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 4

value: male


title: Fmr1 KO P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 3

value: FVB


title: Day 1 culture, biological rep2

value: aortic rings cultured in collagen gels


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL8)

description: We compared the transcription profiles of a type 2B isolated myofibre by microarray competitive hybridization against a pool of soleus and EDL whole muscles.

source_name: Type 2B single myofibre isolated by enzymatic digestion (test)

value: EDL whole muscle

value: type 2B


title: Day 0 aortic ring, biological rep3

description: Gene expression data from freshly isolated aortic rings

source_name: Aortic Ring at day 0

value: aortic ring

value: Fisher 344


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL7)


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL10)


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL9)


title: Day 0 aortic ring, biological rep2


title: WT P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 2

value: cerebral cortex


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL6)


title: Day 0 aortic ring, biological rep1


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL3)


title: 231_LSD1 siRNA_rep2

status: Public on Jul 20 2011

city: Cologne

first: Soyoung

last: Lim

address: Kerpener Str. 62

department: Institute of Pathology

country: Germany

institute: Cologne medical school

description: gene expression data upon LSD1 siRNA treatment

hyb_protocol: Following fragmentation, biotinylated cRNA was hybridized to HG-U133Plus_2.0 microarrays (Affymetrix, Inc., Santa Clara, CA, USA).

scan_protocol: The arrays were scanned in a GeneChip scanner 3000 (Affymetrix).

data_processing: Raw data representing the signal values of gene expression were pre-processed with the GeneChip Operating Software (GCOS) 1.4 Expression console 1.1 was used to obtain quality control data after MAS 5.0 statistical algorithm.

source_name: 231_LSD1 siRNA

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2.5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol: total RNA extraction using RNeasyMini Kit (Qiagen)

tag: cell line

tag: tumor cell type

value: ER-negative breaset cancer cells

value: transfected with LSD1 siRNA


title: 231_LSD1 siRNA_rep3


title: 231_control siRNA_rep3

description: gene expression data upon control siRNA treatment

source_name: 231_control siRNA

value: transfected with control siRNA


title: 231_control siRNA_rep2


title: 231_LSD1 siRNA_rep1


title: DACH1-silenced U87TR-Da, DMEMF

city: Kyoto

first: Akira

last: Watanabe

state: Kyoto

address: Rm504, Miyako Bldg, 233, Isa-cho, kamigyo-ku

country: Japan

institute: CyberomiX Inc

description: Gene expression data from U87MG-derived cell line without DACH1 expression, cultured in serum-containing medium

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.

data_processing: The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: Cells were grown in 10% FBS-containing DMEM or serum-free Neurobasal medium supplemented with N-2, B-27, bFGF and EGF.

treatment_protocol: Cells were exposed to 1 µg/mL doxycycline for 72 hrs.

tag: cell type

value: glioblastoma

value: U87TR-Da (U87MG-derived)

tag: genome/variation

value: without DACH1 expression


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL5)

value: 3 pairs of EDL and soleus whole muscle pooled from 3 wild-type CD1 mice

value: balanced composition of type 1 and type 2B myofibres


title: DACH1-induced U87TR-Da, NBE

description: Gene expression data from U87MG-derived cell line with DACH1 expression, cultured in serum-free medium

value: with DACH1 expression


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL2)


title: WT P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 1

value: male

value: WT

value: purified polyribosomal fractions from a 20-50% sucrose gradient


title: 231_control siRNA_rep1


title: DACH1-induced U87TR-Da, DMEMF

description: Gene expression data from U87MG-derived cell line with DACH1 expression, cultured in serum-containing medium


title: DACH1-silenced U87TR-Da, NBE

description: Gene expression data from U87MG-derived cell line without DACH1 expression, cultured in serum-free medium


title: Gene expression profiling of type 1 single fiber of mouse skeletal muscle (Soleus 2)

value: Soleus whole muscle

value: type 1


title: HumanAorticEndothelialCells_Individual121_OxPAPCTreatment_rep3

first: Casey

last: Romanoski

address: 9500 Gliman Dr.

institute: UCSD

description: OxPAPC

hyb_protocol: According to Affymetrix standard protocol

data_processing: Data was processed with a custom CDF file (mask file HT_U133Amsk.cdf) using Just-RMA in Bioconductor/R and corrected for collection batch using ComBat in R

source_name: HumanAorticEndothelialCells

growth_protocol: Cells were grown in standard 6-well TC plates to confluence at 37C, 5%CO2

extract_protocol: Cytoplasmic RNA was extracted using the Rneasy protocol from Qiagen

treatment_protocol: Cells were treated for 4 hours with or without 40 ug/ul Ox-PAPC

tag: agent

value: OxPAPC

tag: individual id

tag: batch

value: Male

tag: replicate


title: HumanAorticEndothelialCells_Individual121_OxPAPCTreatment_rep2

description: OxPAPC

scan_protocol: According to Affymetrix standard protocol

tag: gender


title: HumanAorticEndothelialCells_Individual121_OxPAPCTreatment_rep1

description: OxPAPC

label_protocol: According to Affymetrix standard protocol


title: HumanAorticEndothelialCells_Individual121_controlTreatment_rep2

description: control

value: control


title: HumanAorticEndothelialCells_Individual121_OxPAPCTreatment_rep4

description: OxPAPC


title: HumanAorticEndothelialCells_Individual119_OxPAPCTreatment_rep3

description: OxPAPC


title: HumanAorticEndothelialCells_Individual119_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual120_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual120_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual120_OxPAPCTreatment_rep3

description: OxPAPC


title: HumanAorticEndothelialCells_Individual119_OxPAPCTreatment_rep4

description: OxPAPC


title: HumanAorticEndothelialCells_Individual120_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual119_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual121_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual118_OxPAPCTreatment_rep3

description: OxPAPC


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL1)

tag: tissue

value: EDL whole muscle

value: type 2B


title: HumanAorticEndothelialCells_Individual119_controlTreatment_rep2

description: control


title: Gene expression profiling of type 2b single fiber of mouse skeletal muscle (EDL4)


title: HumanAorticEndothelialCells_Individual119_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual118_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual118_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual117_OxPAPCTreatment_rep3

description: OxPAPC

value: Female


title: HumanAorticEndothelialCells_Individual117_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual118_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual117_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual117_OxPAPCTreatment_rep4

description: OxPAPC


title: HumanAorticEndothelialCells_Individual116_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual117_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual117_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual116_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual116_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual116_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual115_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual114_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual111_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual113_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual113_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual111_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual110_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual111_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual115_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual110_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual114_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual115_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual114_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual114_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual115_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual113_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual111_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual113_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual108_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual120_OxPAPCTreatment_rep4

description: OxPAPC


title: HumanAorticEndothelialCells_Individual108_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual108_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual108_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual110_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual107_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual107_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual118_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual110_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual107_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual105_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual106_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual103_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual106_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual107_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual106_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual120_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual103_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual101_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual102_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual102_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual103_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual105_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual105_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual104_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual104_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual104_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual102_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual104_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual103_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual106_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual101_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual101_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual102_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual100_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual100_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual100_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual100_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual97_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual99_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual98_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual99_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual96_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual98_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual98_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual95_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual99_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual99_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual97_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual101_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual98_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual95_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual95_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual96_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual97_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual97_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual92_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual96_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual92_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual96_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual93_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual95_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual93_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual92_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual93_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual92_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual93_OxPAPCTreatment_rep2

description: OxPAPC


title: WT P7 mouse cerebral cortex, polyribosomal RNA, biological replicate 3

value: FVB

value: cerebral cortex


title: HumanAorticEndothelialCells_Individual91_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual89_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual89_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual90_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual89_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual90_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual88_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual90_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual86_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual89_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual88_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual91_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual91_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual87_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual86_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual88_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual87_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual87_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual86_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual85_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual85_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual84_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual86_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual85_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual87_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual84_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual84_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual84_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual83_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual83_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual83_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual83_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual71_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual68_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual70_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual69_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual70_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual69_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual66_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual69_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual68_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual70_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual71_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual66_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual68_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual70_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual69_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual68_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual71_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual66_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual66_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual71_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual65_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual65_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual65_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual64_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual65_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual63_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual64_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual64_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual61_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual63_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual57_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual61_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual62_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual57_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual63_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual60_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual56_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual57_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual60_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual56_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual57_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual64_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual62_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual61_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual60_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual60_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual62_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual62_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual61_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual63_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual56_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual56_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual55_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual55_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual54_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual54_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual55_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual54_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual52_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual53_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual53_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual50_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual52_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual51_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual53_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual51_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual54_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual52_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual55_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual51_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual50_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual51_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual53_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual90_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual50_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual88_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual91_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual49_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual50_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual49_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual49_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual49_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual43_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual45_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual48_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual44_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual48_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual43_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual45_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual48_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual42_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual47_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual45_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual44_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual46_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual48_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual47_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual42_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual45_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual46_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual46_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual47_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual47_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual42_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual41_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual43_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual44_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual46_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual41_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual44_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual41_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual39_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual41_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual38_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual39_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual39_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual38_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual38_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual38_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual37_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual39_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual52_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual37_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual37_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual35_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual35_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual35_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual33_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual34_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual34_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual33_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual33_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual34_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual32_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual32_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual35_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual31_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual30_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual31_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual30_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual32_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual34_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual28_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual30_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual28_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual33_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual27_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual26_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual29_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual25_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual28_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual29_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual27_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual31_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual28_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual27_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual29_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual26_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual31_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual26_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual29_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual27_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual30_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual25_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual25_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual25_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual24_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual24_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual24_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual19_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual18_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual19_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual20_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual18_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual22_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual43_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual18_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual24_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual17_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual20_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual21_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual19_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual20_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual18_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual19_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual21_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual21_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual17_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual17_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual21_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual22_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual15_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual15_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual17_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual20_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual15_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual15_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual14_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual14_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual13_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual13_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual10_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual14_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual9_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual7_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual9_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual10_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual10_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual14_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual12_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual9_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual7_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual12_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual13_controlTreatment_rep1

description: control


title: HumanAorticEndothelialCells_Individual12_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual7_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual6_OxPAPCTreatment_rep2

description: OxPAPC


title: HumanAorticEndothelialCells_Individual7_controlTreatment_rep2

description: control


title: HumanAorticEndothelialCells_Individual12_OxPAPCTreatment_rep1

description: OxPAPC


title: HumanAorticEndothelialCells_Individual6_OxPAPCTreatment_rep1

description: OxPAPC